Novelix Pharmaceuticals News

Novelix Pharma Files Q4FY26 SEBI Compliance Certificate

Novelix Pharmaceuticals Limited submits mandatory quarterly certificate under SEBI Depositories Regulations for quarter ended March 31, 2026, confirming proper dematerialisation procedures.

Novelix Pharmaceuticals Files SEBI Disclosure for Share Allotment

Novelix Pharmaceuticals submitted regulatory disclosure under SEBI Takeover Regulations for substantial acquisition by SRINIDHI FINE-CHEMICALS LLP and NARAHARI BELIDE through preferential allotment.

Novelix Pharma Reconstitutes Board Committees

Novelix Pharmaceuticals Limited reconstituted its Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee in a board meeting held on March 30, 2026.

Novelix Pharma Converts Warrants, Director Resigns

Novelix Pharmaceuticals allots 11,50,000 equity shares through warrant conversion raising Rs. 1,72,50,000, while Non-Executive Director Jivamohan Divakar Valluri resigns due to personal commitments.